Lucintel’s latest market report analyzed that human microbiome provides attractive opportunities in the therapeutic industry. The human microbiome market is expected to grow at a CAGR of 22%-24%. In this market, genomics are the largest segment by research technology, whereas infectious are largest by disease.
Download Brochure of this report by clicking on https://www.lucintel.com/human-microbiome-market.aspx
Based on research technology, the human microbiome market is segmented into proteomics, metabolomics, and genomics. The genomics segment accounted for the largest share of the market in 2020 due to increasing number of projects funded by private and government bodies.
Browse in-depth TOC on “Human Microbiome Market”
XX – Tables
XX – Figures
The human microbiome market is marked by the presence of several big and small players. Some of the prominent players offering human microbiome include Enterome Bioscience, Seres Therapeutics, 4D Pharma, Rebiotix, Yakult Honsha, Osel, Vedanta Biosciences, Synthetic Biologics, DuPont, and BiomX.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link email@example.com.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.